Orthopedic Burn Reach AlloSource's focus on cartilage and burn tissue creates opportunities with orthopedic surgery and burn care networks. Differentiated offerings such as AceConnex Pre-Sutured Fascia and ProChondrix CR enhance joint reconstruction and soft tissue augmentation. Leverage participation in industry events like the ICRS World Congress to accelerate surgeon engagement and product adoption.

Enterprise Partnerships The Cigna Bronze Healthy Workforce designation signals payer and employer interest in wellness and coverage programs. Target large health systems, integrated delivery networks, and corporate health plans to expand product access and bundled tissue solutions. Align procurement with existing systems by leveraging Epicor, DocuSign, and digital contracting to shorten sales cycles.

Data Driven Sourcing AlloSource can differentiate on supply chain reliability and traceability using its tech stack, including Epicor, Snowflake, and DocuSign. Offer programs such as vendor managed inventory and real-time inventory visibility to hospitals to reduce stockouts and procurement friction. Emphasize compliance and data transparency as a service differentiator.

Pipeline Cross Sell With a broad portfolio of over 200 graft types and ongoing launches such as AlloMend Duo Acellular Dermal Matrix, AceConnex Pre-Sutured Fascia, and AlloFuse Microfibers Demineralized Bone, there are multiple cross-sell opportunities across orthopedics, plastics, and reconstructive surgery. Map accounts by surgeon specialty and surgical unit to tailor clinical data and demonstrations to joint repair, soft tissue reconstruction, and burn care needs. Build a pipeline around evidence from clinical outcomes and cryopreservation expertise.

Mission Driven Advantage Nonprofit accreditation by the American Association of Tissue Banks and donor-centered model can be positioned as a risk-mitigation and quality differentiator with hospitals, ASC networks, and insurers. Leverage these credentials in procurement and RFPs to emphasize reliability, ethics, and patient outcomes as strategic buying criteria.